<DOC>
	<DOCNO>NCT00430053</DOCNO>
	<brief_summary>RATIONALE : Gathering information patient cutaneous T-cell lymphoma time may help doctor learn disease . PURPOSE : This natural history study collect disease-related health information time patient cutaneous T-cell lymphoma .</brief_summary>
	<brief_title>Clinical Evaluations Laboratory Studies Study Disease Course Patients With Cutaneous T-Cell Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Follow disease course patient cutaneous T-cell lymphoma . - Provide patient population study proteomic molecular analysis . - Develop mechanism screen Tumor Board enrollment patient therapeutic clinical trial . Secondary - Develop tissue bank future disease study use specimens patient . - Provide community outreach offer second opinion regard treatment disease patient , limited case , provide standard-of-care treatment patient . - Develop algorithm screen evaluate disease patient . OUTLINE : Patients undergo disease assessment physical examination , full-body photographic documentation skin disease , biopsy , blood sample baseline least annually thereafter . Proteomic molecular method use analyze sample . Biopsies may examine use histologic immunohistochemical method . Blood may analyze polymerase chain reaction clonal T-cell gene rearrangement flow cytometry . PROJECTED ACCRUAL : A total 100 patient accrue study within 5 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Histologically confirm stage IAIVB cutaneous Tcell lymphoma ( CTCL ) ( mycosis fungoides Sézary syndrome ) Other histologically clinically confirm primary secondary CTCL Histologically clinically confirm preCTCL skin condition , include large plaque parapsoriasis lymphomatoid papulosis Measurable disease skin lesion assessment Sézary cell count PATIENT CHARACTERISTICS : Age Over 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Human Tcell lymphotrophic virus ( HTLV ) I/II negative Not pregnant Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage I cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage II cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage I mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage II mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage III mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage IV mycosis fungoides/Sezary syndrome</keyword>
</DOC>